Dr. Douglas M. Freedman, MD

Dr. Freedman practices at Cedars-Sinai Medical Care Foundation in Beverly Hills, California.

Dr. Freedman's NPI, 1801846423, was assigned on May 12, 2006. Dr. Freedman graduated from Yale University School of Medicine in 1990. Dr. Freedman holds California license G076414.

Dr. Freedman's primary practice is Cedars-Sinai Medical Care Foundation, at 8501 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 385-3200.

Dr. Freedman's primary practice is Cedars-Sinai Medical Care Foundation in Beverly Hills, California. Dr. Freedman is also affiliated with Providence Saint John's Health Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Freedman practices. Vendor and product names are available with a free account.

Hand surgery is Dr. Freedman's primary specialty in the NPI Registry, under taxonomy code 207XS0106X. Dr. Freedman is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Freedman's licenses on file in 2 states: California and New York.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, carpal tunnel syndrome, enthesopathy in arms, hand joint or tendon inflammation, joint cyst, joint pain and minor injury to a limb among the conditions Dr. Freedman treats.

CMS data shows 2,435 Medicare services from Dr. Freedman across 16 procedure codes in 2024, for 572 Medicare patients. Medicare paid $124,806 for them.

CMS counts 572 Medicare patients who saw Dr. Freedman in 2024. The largest group is 75 to 84, with 240 patients. 75% of them have high cholesterol, and 71% have arthritis. 2% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Freedman's median patient age at 72, with 50% women.

In 2024, Dr. Freedman wrote 76 Medicare Part D claims for 54 patients. 99% of them were for generic drugs. CMS names the drug for 32 of them, across 1 drug with 11 or more claims each, at $84 in total drug cost. In 2023, CMS named 25 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Freedman for performance year 2024, reported individually. Dr. Freedman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Freedman as offering telehealth.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Freedman. Dr. Freedman's most frequent co-author is Michiyuki Kono, MD.

CMS Open Payments shows 3 general payments to Dr. Freedman from 3 drug and device companies from 2017 to 2024. Speaker and faculty fees make up the largest share, 80% of the total. Abbott Laboratories paid the most, $163.

Dmand AI lists 1 award for Dr. Freedman, most recently CMS Stage 1 2012 in 2011.

Dr. Freedman graduated from Yale University School of Medicine in 1990.

Dr. Freedman is in network with 3 carriers, including Blue Cross Blue Shield of Massachusetts, HCSC and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.